GSK-117119

Study Sponsor: GSK

Study Title

Immunogenicity and safety study of GSK Biologicals’ Infanrix hexa at 2, 4 and 6 months of age in healthy infants

Medicine or Vaccine (generic name)

Combined Diphtheria, Tetanus, Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), Inactivated Polio Vaccine; Haemophilus influenzae type b

Sponsor Identification Number

117119

Trial Registry Identification Number(#'s)

NCT02096263 2013-004304-19

Medical Condition

acellular pertussis; Diphtheria; Haemophilus influenzae type b; Hepatitis B; Poliomyelitis; Tetanus

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

December 2018